# Trade Mark Journal No.2025/047 21 November 2025

## WO0000001885483 (5)

Office of origin: United States of America

Date of International Registration:10 October 2025
Date of designation in the UK: 10 October 2025

International priority date claimed: 22 August 2025 (United States of America) (99351817)

Class 5
  Pharmaceutical preparations for the treatment of blood disorders, hemolytic anemia and diseases effecting red blood cells.

Agios Pharmaceuticals, Inc.

Representative: Maury M. Tepper, III Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609, UNITED STATES OF AMERICA